@drsgraff.bsky.social on Bluesky

JavaScript RequiredThis is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is. Learn more about Bluesky at bsky.social and atproto.com.

Post

Stephanie L. Graff, MD FACP FASCO

drsgraff.bsky.social

did:plc:3q3jzd25lg65tydtyb24oxlv

EMBER3 shows benefit of imlunestrant in patients with HR+ MBC and mESR1 and for the combination of imlunestrant and Abemaciclib for all patients, regardless of ESR1 status #SABCS24 @sabcs.bsky.social @breastcancerdoc.bsky.social @oncoalert.bsky.social

2024-12-11T15:34:54.559Z